257 related articles for article (PubMed ID: 27618100)
1. Early Activation of MAPK p44/42 Is Partially Involved in DON-Induced Disruption of the Intestinal Barrier Function and Tight Junction Network.
Springler A; Hessenberger S; Schatzmayr G; Mayer E
Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27618100
[TBL] [Abstract][Full Text] [Related]
2. Deoxynivalenol impairs porcine intestinal barrier function and decreases the protein expression of claudin-4 through a mitogen-activated protein kinase-dependent mechanism.
Pinton P; Braicu C; Nougayrede JP; Laffitte J; Taranu I; Oswald IP
J Nutr; 2010 Nov; 140(11):1956-62. PubMed ID: 20861219
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of deoxynivalenol-induced endocytosis and degradation of tight junction proteins in jejunal IPEC-J2 cells involve selective activation of the MAPK pathways.
Li E; Horn N; Ajuwon KM
Arch Toxicol; 2021 Jun; 95(6):2065-2079. PubMed ID: 33847777
[TBL] [Abstract][Full Text] [Related]
4. Vulnerability of polarised intestinal porcine epithelial cells to mycotoxin deoxynivalenol depends on the route of application.
Diesing AK; Nossol C; Dänicke S; Walk N; Post A; Kahlert S; Rothkötter HJ; Kluess J
PLoS One; 2011 Feb; 6(2):e17472. PubMed ID: 21364771
[TBL] [Abstract][Full Text] [Related]
5. Nontoxic concentrations of OTA aggravate DON-induced intestinal barrier dysfunction in IPEC-J2 cells via activation of NF-κB signaling pathway.
Ying C; Hong W; Nianhui Z; Chunlei W; Kehe H; Cuiling P
Toxicol Lett; 2019 Sep; 311():114-124. PubMed ID: 31026484
[TBL] [Abstract][Full Text] [Related]
6. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression.
Pinton P; Nougayrède JP; Del Rio JC; Moreno C; Marin DE; Ferrier L; Bracarense AP; Kolf-Clauw M; Oswald IP
Toxicol Appl Pharmacol; 2009 May; 237(1):41-8. PubMed ID: 19289138
[TBL] [Abstract][Full Text] [Related]
7. Deoxynivalenol and its metabolite deepoxy-deoxynivalenol: multi-parameter analysis for the evaluation of cytotoxicity and cellular effects.
Springler A; Hessenberger S; Reisinger N; Kern C; Nagl V; Schatzmayr G; Mayer E
Mycotoxin Res; 2017 Feb; 33(1):25-37. PubMed ID: 27817099
[TBL] [Abstract][Full Text] [Related]
8. Effects of Deoxynivalenol and Mycotoxin Adsorbent Agents on Mitogen-Activated Protein Kinase Signaling Pathways and Inflammation-Associated Gene Expression in Porcine Intestinal Epithelial Cells.
Yu YH; Lai YH; Hsiao FS; Cheng YH
Toxins (Basel); 2021 Apr; 13(5):. PubMed ID: 33922863
[TBL] [Abstract][Full Text] [Related]
9. Toxicity of deoxynivalenol and its acetylated derivatives on the intestine: differential effects on morphology, barrier function, tight junction proteins, and mitogen-activated protein kinases.
Pinton P; Tsybulskyy D; Lucioli J; Laffitte J; Callu P; Lyazhri F; Grosjean F; Bracarense AP; Kolf-Clauw M; Oswald IP
Toxicol Sci; 2012 Nov; 130(1):180-90. PubMed ID: 22859312
[TBL] [Abstract][Full Text] [Related]
10. PPARγ activation inhibits endocytosis of claudin-4 and protects against deoxynivalenol-induced intestinal barrier dysfunction in IPEC-J2 cells and weaned piglets.
Li E; Li C; Horn N; Ajuwon KM
Toxicol Lett; 2023 Feb; 375():8-20. PubMed ID: 36596350
[TBL] [Abstract][Full Text] [Related]
11. Deoxynivalenol affects in vitro intestinal epithelial cell barrier integrity through inhibition of protein synthesis.
De Walle JV; Sergent T; Piront N; Toussaint O; Schneider YJ; Larondelle Y
Toxicol Appl Pharmacol; 2010 Jun; 245(3):291-8. PubMed ID: 20362602
[TBL] [Abstract][Full Text] [Related]
12. Assessing Mixture Effects of Cereulide and Deoxynivalenol on Intestinal Barrier Integrity and Uptake in Differentiated Human Caco-2 Cells.
Beisl J; Varga E; Braun D; Warth B; Ehling-Schulz M; Del Favero G; Marko D
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33806705
[TBL] [Abstract][Full Text] [Related]
13. Effects of cigarette smoke on barrier function and tight junction proteins in the bronchial epithelium: protective role of cathelicidin LL-37.
Tatsuta M; Kan-O K; Ishii Y; Yamamoto N; Ogawa T; Fukuyama S; Ogawa A; Fujita A; Nakanishi Y; Matsumoto K
Respir Res; 2019 Nov; 20(1):251. PubMed ID: 31706310
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus and cyclosporine A alter barrier function in renal proximal tubular cells through stimulation of ERK1/2 signaling and claudin-1 expression.
Martin-Martin N; Ryan G; McMorrow T; Ryan MP
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F672-82. PubMed ID: 19955189
[TBL] [Abstract][Full Text] [Related]
15. Mycotoxin deoxynivalenol (DON) mediates biphasic cellular response in intestinal porcine epithelial cell lines IPEC-1 and IPEC-J2.
Diesing AK; Nossol C; Panther P; Walk N; Post A; Kluess J; Kreutzmann P; Dänicke S; Rothkötter HJ; Kahlert S
Toxicol Lett; 2011 Jan; 200(1-2):8-18. PubMed ID: 20937367
[TBL] [Abstract][Full Text] [Related]
16. Deoxynivalenol, but not E. coli lipopolysaccharide, changes the response pattern of intestinal porcine epithelial cells (IPEC-J2) according to its route of application.
Kluess JW; Kahlert S; Kröber A; Diesing AK; Rothkötter HJ; Wimmers K; Dänicke S
Toxicol Lett; 2015 Dec; 239(3):161-71. PubMed ID: 26417708
[TBL] [Abstract][Full Text] [Related]
17. EPA and DHA inhibit endocytosis of claudin-4 and protect against deoxynivalenol-induced intestinal barrier dysfunction through PPARγ dependent and independent pathways in jejunal IPEC-J2 cells.
Li E; Horn N; Ajuwon KM
Food Res Int; 2022 Jul; 157():111420. PubMed ID: 35761666
[TBL] [Abstract][Full Text] [Related]
18. Nontoxic-dose deoxynivalenol aggravates lipopolysaccharides-induced inflammation and tight junction disorder in IPEC-J2 cells through activation of NF-κB and LC3B.
Ge L; Lin Z; Le G; Hou L; Mao X; Liu S; Liu D; Gan F; Huang K
Food Chem Toxicol; 2020 Nov; 145():111712. PubMed ID: 32877744
[TBL] [Abstract][Full Text] [Related]
19. ERK1/2 mitogen-activated protein kinase mediates downregulation of intestinal tight junction proteins in heat stress-induced IBD model in pig.
Yong Y; Li J; Gong D; Yu T; Wu L; Hu C; Liu X; Yu Z; Ma X; Gooneratne R; Abd El-Aty AM; Chen J; Ju X
J Therm Biol; 2021 Oct; 101():103103. PubMed ID: 34879918
[TBL] [Abstract][Full Text] [Related]
20. Galacto-oligosaccharides Protect the Intestinal Barrier by Maintaining the Tight Junction Network and Modulating the Inflammatory Responses after a Challenge with the Mycotoxin Deoxynivalenol in Human Caco-2 Cell Monolayers and B6C3F1 Mice.
Akbari P; Braber S; Alizadeh A; Verheijden KA; Schoterman MH; Kraneveld AD; Garssen J; Fink-Gremmels J
J Nutr; 2015 Jul; 145(7):1604-13. PubMed ID: 26019243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
